09 noviembre 2009

Aplidin® Clinical Study in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia .

NCT00780143 is an interventional clinical trial that is for Relapsed/Refractory Leukemia conditions and was started in November of 2007. This trial has 35 people enrolled who are within the adult and senior age range. This trial is funded by an industry organization. The specific sponsors / contributors of this trial are as follows: PharmaMar. The following interventions were used in this trial: (drug) Plitidepsin plus Cytarabine. This trial is reported / scheduled to have been completed in November of 2009.
.